Skip to main content
Frontline Gastroenterology logoLink to Frontline Gastroenterology
. 2020 Apr 3;11(3):e1. doi: 10.1136/flgastro-2018-101057corr1

Correction: Antibiotics and probiotics in inflammatory bowel disease: when to use them?

PMCID: PMC7223347  PMID: 32419919

Abraham B, Quigley EMM. Antibiotics and probiotics in inflammatory bowel disease: when to use them? Frontline Gastroenterology 2020;11:62–9.

A number of studies cited in this paper assessed a probiotic formulation previously known as VSL#3. The probiotic formulation that was assessed in these studies is now known by the generic name 'De Simone Formulation'. The current product known as VSL#3 is not the same formulation as the De Simone Formulation. The De Simone Formulation is available under the brand names Visbiome (USA) and Vivomixx (Europe). doi: 10.1136/flgastro-2018–1 00 617


Articles from Frontline Gastroenterology are provided here courtesy of BMJ Publishing Group

RESOURCES